<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="have been described [52, 54]. Several cases were treated with" exact="ganciclovir" post="or with valganciclovir, some with fatal outcome despite therapy."/>
 <result pre="measurements of CMV in blood samples. Emerging strains resistant to" exact="ganciclovir" post="pose a therapeutic challenge for which foscarnet or cidofovir"/>
 <result pre="to ganciclovir pose a therapeutic challenge for which foscarnet or" exact="cidofovir" post="may become alternative antiviral agents [58]. Valganciclovir has recently"/>
 <result pre="reduced in liver transplant recipients who receive antiviral prophylaxis with" exact="valganciclovir" post="or oral ganciclovir for the first 3 months following"/>
 <result pre="transplant recipients who receive antiviral prophylaxis with valganciclovir or oral" exact="ganciclovir" post="for the first 3 months following liver transplantation. CMV"/>
 <result pre="infection to full-blown clinical disease [67]. Preemptive therapy with oral" exact="ganciclovir" post="or intravenous ganciclovir or valganciclovir resulted in reduction of"/>
 <result pre="clinical disease [67]. Preemptive therapy with oral ganciclovir or intravenous" exact="ganciclovir" post="or valganciclovir resulted in reduction of CMV disease by"/>
 <result pre="[67]. Preemptive therapy with oral ganciclovir or intravenous ganciclovir or" exact="valganciclovir" post="resulted in reduction of CMV disease by 70 %"/>
 <result pre="very rapid [66]. For antiviral prophylaxis, antiviral drugs such as" exact="ganciclovir" post="and valganciclovir are administered to patients at risk of"/>
 <result pre="[66]. For antiviral prophylaxis, antiviral drugs such as ganciclovir and" exact="valganciclovir" post="are administered to patients at risk of CMV disease"/>
 <result pre="as anti-CMV prophylaxis after liver transplantation has been supplanted by" exact="ganciclovir" post="and valganciclovir because of their superior efficacy [71, 76,"/>
 <result pre="prophylaxis after liver transplantation has been supplanted by ganciclovir and" exact="valganciclovir" post="because of their superior efficacy [71, 76, 77]. Prophylactic"/>
 <result pre="antiviral treatment of CMV disease after liver transplantation is intravenous" exact="ganciclovir" post="along with a reduction in the degree of pharmacologic"/>
 <result pre="disease, treatment options include foscarnet, cidofovir, CMV hyperimmune globulins, or" exact="leflunomide" post="[69]. Compartmentalized CMV disease refers to clinical syndromes wherein"/>
 <result pre="indicated for end organ disease and includes foscarnet, ganciclovir, and" exact="cidofovir" post="[86]. Varicella Zoster Virus Primary varicella infection is usually"/>
 <result pre="No specific therapy for adenovirus hepatitis is currently available, and" exact="cidofovir" post="has been recently suggested as an optional treatment [1]."/>
 <result pre="infectionHerpesviridae20112110.1186/2042-4280-2-121429244 12.LevitskyVMasucciMGManipulation of immune responses by Epstein-Barr virusVirus Res200288718610.1016/S0168-1702(02)00121-112297328 13.KagoyaYHangaishiATakahashiTImaiYKurokawaMHigh-dose" exact="dexamethasone" post="therapy for severe thrombocytopenia and neutropenia induced by EBV"/>
 <result pre="transplantationLancet20003552032610.1016/S0140-6736(00)02350-310885354 67.WalkerJKScholzLMScheetzMHGallonLGKaufmanDBRachwalskiEJAbecassisMMet al.Leukopenia complicates cytomegalovirus prevention after renal transplantation with" exact="alemtuzumab" post="inductionTransplantation2007838748210.1097/01.tp.0000257923.69422.4d17460557 68.HodsonEMJonesCAWebsterACStrippoliGFBarclayPGKableKVimalachandraDet al.Antiviral medications to prevent cytomegalovirus disease and"/>
 <result pre="in liver transplantation: a randomized trial comparing a combination of" exact="ganciclovir" post="and acyclovir to acyclovir. NIDDK Liver Transplantation DatabaseTransplantation199764667310.1097/00007890-199707150-000139233703 71.GaneESalibaFValdecasasGJO’GradyJPescovitzMDLymanSRobinsonCARandomised"/>
 <result pre="Transplantation DatabaseTransplantation199764667310.1097/00007890-199707150-000139233703 71.GaneESalibaFValdecasasGJO’GradyJPescovitzMDLymanSRobinsonCARandomised trial of efficacy and safety of oral" exact="ganciclovir" post="in the prevention of cytomegalovirus disease in liver-transplant recipients."/>
 <result pre="organ transplant recipientsClin Infect Dis2002358667210.1086/34238512228824 77.PayaCHumarADominguezEWashburnKBlumbergEAlexanderBFreemanRet al.Efficacy and safety of" exact="valganciclovir" post="vs. oral ganciclovir for prevention of cytomegalovirus disease in"/>
 <result pre="Infect Dis2002358667210.1086/34238512228824 77.PayaCHumarADominguezEWashburnKBlumbergEAlexanderBFreemanRet al.Efficacy and safety of valganciclovir vs. oral" exact="ganciclovir" post="for prevention of cytomegalovirus disease in solid organ transplant"/>
 <result pre="disease in solid organ transplant recipientsAm J Transplant200446112010.1111/j.1600-6143.2004.00382.x15023154 78.AsbergAHansenCNReubsaetLDetermination of" exact="ganciclovir" post="in different matrices from solid organ transplanted patients treated"/>
</results>
